<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05006274</url>
  </required_header>
  <id_info>
    <org_study_id>IRU2018-51K</org_study_id>
    <nct_id>NCT05006274</nct_id>
  </id_info>
  <brief_title>Intraoperative Soft Tissue Balance in TKA</brief_title>
  <official_title>Evaluation of Intraoperative Soft-tissue Balance and Postoperative Functional Recovery After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington Hospital Healthcare System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Washington Hospital Healthcare System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this evaluation is to evaluate the intraoperative soft tissue balance as&#xD;
      assessed by the Orthosensor device, to measure the perioperative gait and function with the&#xD;
      Muvr tracking device, and to correlate this soft tissue balance with early functional&#xD;
      outcomes in the Persona total knee system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single surgeon, prospective, controlled study consisting of 50 patients with a&#xD;
      primary indication of OA who are eligible for primary total knee arthroplasty using the&#xD;
      Persona total knee system.&#xD;
&#xD;
      The patients are equally divided in two groups; patients in group 1 will receive traditional,&#xD;
      manual soft-tissue balancing during surgery. For the purpose of the study, the balance will&#xD;
      be quantitatively assessed at the end of the case, by means of surgeon-blinded VERASENSE&#xD;
      measurements before and after cementation. For the patients in Group 2, intra-operative&#xD;
      sensor feedback will be used in creating a quantitatively balanced knee (VERASENSE,&#xD;
      OrthoSensor Inc.). Thereby, a quantitatively balanced knee is characterized by a mediolateral&#xD;
      load differential below 15lbs at 10-45-90 degrees of flexion.&#xD;
&#xD;
      Post-operatively, the patients will be evaluated using the Muvr device at the day of surgery,&#xD;
      day of discharge and 2, 6, and 12 weeks, and 1 year postoperatively. This device will provide&#xD;
      quantitative feedback on different gait metrics as well as function during activities of&#xD;
      daily living such as stair climbing / stair descent, walking, and timed get up and go&#xD;
      testing.&#xD;
&#xD;
      During each post-operative visit, the following metrics will be recorded:&#xD;
&#xD;
        -  Active and passive range of motion&#xD;
&#xD;
        -  Implant alignment&#xD;
&#xD;
        -  Patient reported outcomes by means of Knee Society Score (KSS), Western Ontario and&#xD;
           McMaster Universities Osteoarthritis Index (WOMAC) and Forgotten Joint Score (FJS)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 13, 2021</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Active and passive range of motion</measure>
    <time_frame>2 weeks</time_frame>
    <description>Flexion and extension measurements of knee</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Active and passive range of motion</measure>
    <time_frame>6 weeks</time_frame>
    <description>Flexion and extension measurements of knee</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Active and passive range of motion</measure>
    <time_frame>12 weeks</time_frame>
    <description>Flexion and extension measurements of knee</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Active and passive range of motion</measure>
    <time_frame>1 year</time_frame>
    <description>Flexion and extension measurements of knee</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant alignment</measure>
    <time_frame>2 weeks post-operatively</time_frame>
    <description>Radiographic assessments</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant alignment</measure>
    <time_frame>6 weeks post-operatively</time_frame>
    <description>Radiographic assessments</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant alignment</measure>
    <time_frame>12 weeks post-operatively</time_frame>
    <description>Radiographic assessments</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Implant alignment</measure>
    <time_frame>1 year post-operatively</time_frame>
    <description>Radiographic assessments</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Society Score (KSS)</measure>
    <time_frame>2 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-100, higher score better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>2 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-96, lower score means less disability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forgotten Joint Score (FJS)</measure>
    <time_frame>2 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-100, 100 being better score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Society Score (KSS)</measure>
    <time_frame>12 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-100, higher score better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>12 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-96, lower score means less disability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forgotten Joint Score (FJS)</measure>
    <time_frame>12 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-100, 100 being better score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Society Score (KSS)</measure>
    <time_frame>52 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-100, higher score better.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)</measure>
    <time_frame>52 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-96, lower score means less disability</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Forgotten Joint Score (FJS)</measure>
    <time_frame>52 weeks post-operatively</time_frame>
    <description>Patient-reported outcome surveys assessing pain and function after total knee arthroplasty. Range 0-100, 100 being better score</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <arm_group>
    <arm_group_label>Group 1-Traditional soft tissue balance</arm_group_label>
    <description>Patients in group 1 will receive traditional, manual soft-tissue balancing during surgery. For the purpose of the study, the balance will be quantitatively assessed at the end of the case, by means of surgeon-blinded VERASENSE measurements before and after cementation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2-Soft tissue balance using VERASENSE</arm_group_label>
    <description>For the patients in Group 2, intra-operative sensor feedback will be used in creating a quantitatively balanced knee (VERASENSE, OrthoSensor Inc.). Thereby, a quantitatively balanced knee is characterized by a mediolateral load differential below 15lbs at 10-45-90 degrees of flexion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Persona Trabecular Metal Tibia</intervention_name>
    <description>Total knee arthroplasty</description>
    <arm_group_label>Group 1-Traditional soft tissue balance</arm_group_label>
    <arm_group_label>Group 2-Soft tissue balance using VERASENSE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Verasense technology</intervention_name>
    <description>Instrumented tibial trial component</description>
    <arm_group_label>Group 1-Traditional soft tissue balance</arm_group_label>
    <arm_group_label>Group 2-Soft tissue balance using VERASENSE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MUVR</intervention_name>
    <description>Knee motion and gait sensing wearable device</description>
    <arm_group_label>Group 1-Traditional soft tissue balance</arm_group_label>
    <arm_group_label>Group 2-Soft tissue balance using VERASENSE</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy individuals having elective primary knee replacement&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient has a primary indication of osteoarthritis and is eligible for primary total&#xD;
             knee arthroplasty using the Persona total knee system&#xD;
&#xD;
          2. Patient is willing and able to provide written Informed Consent prior to study surgery&#xD;
&#xD;
          3. Patient is willing and able to complete scheduled study procedures and follow-up&#xD;
             evaluations as described in the Informed Consent Form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient does not have a primary indication of osteoarthritis&#xD;
&#xD;
          2. Patient does not have access to internet or mobile device or understand how to use&#xD;
             phone/app&#xD;
&#xD;
          3. Patient is not eligible or will not receive the Persona total knee system&#xD;
&#xD;
          4. Patient has not provided written Informed Consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alexander Sah, MD</last_name>
    <phone>510-818-7200</phone>
    <email>info@SahOrtho.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexander Alexander, MD</last_name>
    <phone>510-818-7200</phone>
    <email>info@SahOrtho.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington Hospital</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Sah, MD</last_name>
      <phone>510-818-7200</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 21, 2021</study_first_submitted>
  <study_first_submitted_qc>August 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 14, 2021</last_update_submitted>
  <last_update_submitted_qc>August 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington Hospital Healthcare System</investigator_affiliation>
    <investigator_full_name>Alexander Sah, MD</investigator_full_name>
    <investigator_title>Physician and Research Chair, Institute for Joint Restoration and Research</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

